ASH Conference 2021: Graft-vs-Host Disease Treatment Advances
Doris M. Ponce, MD, a hematologic oncologist, discusses research on graft-vs-host disease (GVHD) presented at the ASH 2021 Annual Conference, including therapeutic advances for GVHD prevention and treatment, role of the microbiome in disease outcomes, and future direction of therapy.
